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Pax5 Promotes B Lymphopoiesis and Blocks
T Cell Development by Repressing Notch1
inactivation converts committed pro-B cells with a re-
stricted B lymphoid potential into early progenitors with
a broad developmental potential (Mikkola et al., 2002).
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Vienna Biocenter At the molecular level, Pax5 fulfills a dual role in B lineage
commitment. It activates the transcription of B cell-spe-Dr. Bohr-Gasse 7
A-1030 Vienna cific genes such as CD19 and BLNK, which code for
molecules facilitating (pre)B cell receptor signaling (NuttAustria
et al., 1998; Schebesta et al., 2002b). At the same time,
Pax5 represses the transcription of the myeloid M-CSF-R,
myeloperoxidase, and other non-B lymphoid genes that
are promiscuously expressed in uncommitted progeni-Summary
tors. The repression of lineage-inappropriate genes pro-
vides a molecular mechanism for the suppression ofThe B lineage commitment factor Pax5 (BSAP) is ex-
clusively expressed in B lymphocytes of the blood sys- alternative cell fates by Pax5 (Nutt et al., 1999).
The role of Pax5 in early B cell development has so fartem. To study the effect of Pax5 on the development
of other hematopoietic lineages, we generated a het- been elucidated by loss-of-function analyses (Sche-
besta et al., 2002a). Here, we have employed a gain-erozygous knockin mouse carrying a Pax5 minigene
under the control of the Ikaros locus. Conditional and of-function strategy to investigate whether precocious
Pax5 expression in early progenitors is sufficient to pro-constitutive activation of the IkPax5 allele demonstrated
that precocious Pax5 expression in hematopoietic stem mote B cell development at the expense of other hema-
topoietic lineages. As the Ikaros (Ik) gene is expressedcells and progenitors failed to interfere with myeloid
development and only weakly affected erythroblast in all hematopoietic cell types including stem cells and
multipotent progenitors (Morgan et al., 1997; Klug et al.,formation. Instead, pan-hematopoietic Pax5 expres-
sion strongly promoted B cell development at the ex- 1998; Kelley et al., 1998), we have generated a condi-
tional Ikneo allele by inserting a Pax5 minigene togetherpense of T lymphopoiesis. Pax5 thereby interfered with
T lineage commitment and early thymocyte develop- with a floxed neomycin (neo) resistance gene into the
Ik locus. Conditional activation of the Ikneo allele, consti-ment by repressing the transcription of the T cell spec-
ification gene Notch1. tutive expression of the IkPax5 gene, as well as competi-
tive bone marrow reconstitution, all revealed that pan-
hematopoietic Pax5 expression failed to interfere withIntroduction
myeloid development and only weakly affected erythro-
poiesis. Instead, ectopic Pax5 expression efficiently pro-The pluripotent hematopoietic stem cell (HSC) continu-
ously regenerates all erythroid, myeloid, and lymphoid moted B lymphopoiesis at the expense of T cell develop-
ment. Pax5 was furthermore shown to repress thecell types by differentiating to more restricted progeni-
tors, which undergo commitment to one of several path- transcription of Notch1, which is both necessary and
sufficient for the commitment of lymphoid progenitorsways and then develop into mature cells of the selected
lineage. The entry of lymphoid progenitors into the B to the T cell pathway (Radtke et al., 1999; Pui et al.,
1999). Together these data demonstrate that precociouscell pathway depends on the transcription factors E2A,
EBF, and Pax5 (BSAP). E2A and EBF coordinately acti- Pax5 expression strongly skews the developmental po-
tential of lymphoid progenitors by efficiently directingvate the expression of B cell-specific genes, which are
essential for the generation of the earliest B cell progeni- them into the B cell pathway and by simultaneously
tors (pro-B cells) at the onset of B lymphopoiesis (re- interfering with Notch1-dependent T lymphopoiesis.
viewed by Schebesta et al., 2002a). The activation of
the B cell-specific transcription program is, however, not
sufficient to commit early progenitors to the B lymphoid Results
lineage in the absence of Pax5 expression. Homozygous
mutation of the Pax5 gene arrests B cell development Insertion of a Conditionally Expressed Pax5
at an early pro-B cell stage in the bone marrow (Urba´nek Minigene into the Ikaros Locus
et al., 1994; Nutt et al., 1997). Pax5/ pro-B cells express A Pax5 minigene was brought under the control of the
normal levels of E2A and EBF (Nutt et al., 1997) and yet Ikaros locus by inserting, upstream of the translation
retain a broad developmental potential and extensive start codon in exon 2, an expression cassette consisting
self-renewal capacity characteristic of early progenitors of a floxed neomycin resistance gene and the Pax5
(Nutt et al., 1999; Rolink et al., 1999). The restoration of cDNA linked via an IRES sequence to a GFP gene (Figure
Pax5 expression in Pax5/ pro-B cells suppresses this 1A). Heterozygous Ikneo/ mice, obtained by blastocyst
multilineage potential and simultaneously promotes de- injection of targeted ES cells (Figure 1B), were crossed
velopment to mature B cells (Nutt et al., 1999). Con- with a Sycp1-cre transgenic line (Vidal et al., 1998) to
versely, the loss of Pax5 expression by conditional gene generate IkPax5/ mice by Cre-mediated deletion of the
neo gene in the male germline (Figure 1A). The neo-
Pax5-GFP insertion of the targeted allele is predicted to1Correspondence: busslinger@nt.imp.univie.ac.at
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Figure 1. Insertion of a Pax5 Minigene into the Ikaros Locus
(A) Structure of the targeted Ikaros gene. The indicated expression cassette was inserted immediately upstream of the translation start codon
in Ikaros exon 2. The expression cassette contained the neomycin (neo) resistance gene, flanked by two loxP sites (arrowheads), upstream
of the human Pax5 cDNA, which was linked via an internal ribosomal entry sequence (IRES) to a GFP gene and the 3 polyadenylation (pA)
region of the rabbit -globin gene. Correct targeting was verified by Southern blot analysis of AvrII-digested DNA with the indicated 2.5 kb
AvrII-EcoRI probe. The lengths of the respective AvrII fragments are shown in kb. A, AvrII; B, BsaI; N, NheI; P, PstI; DT-A, diphteria toxin A;
tk, thymidine kinase; and 3SS, 3 splice site.
(B) Southern blot analysis of AvrII-digested DNA isolated from the indicated mice.
(C) Ikaros expression. Whole cell extracts prepared from thymocytes of 3-week-old mice were analyzed by Western blotting with anti-Ikaros
and anti-TBP antibodies. The different Ikaros isoforms are indicated together with the sizes of marker proteins (in kDa).
(D) Pax5 expression. Whole cell lysates prepared from sorted Mac-1 bone marrow cells, total thymocytes, and in vitro cultured wild-type
(wt) pro-B cells were analyzed by sequential Western blotting with anti-Pax5 and anti-tubulin antibodies.
correspond to an Ikaros null mutation. Indeed, CD19 analyzed, including stem cells and multipotent progeni-
tors (Morgan et al., 1997; Klug et al., 1998; Kelley etB lymphocytes and CD11c dendritic cells were absent
in bone marrow and spleen, while thymocytes devel- al., 1998). We therefore investigated the hematopoietic
expression pattern of the Ikneo and IkPax5 alleles by flowoped only postnatally in homozygous Ikneo/neo mice (data
not shown) as described for Ik/ mice (Wang et al., cytometric analysis of the thymus and bone marrow of
heterozygous Ikneo/ and IkPax5/ mice. Both alleles gave1996; Wu et al., 1997). Moreover, no Ikaros isoforms
could be detected in Ikneo/neo thymocytes by Western blot rise to similar GFP expression in B cells (B220CD19),
immature thymocytes (CD4CD8), granulocytes (Gr-1analysis with an antibody directed against C-terminal
Ikaros sequences (Figure 1C), further demonstrating that Mac-1), monocyte/macrophages (M-CSF-RMac-1),
and erythroid progenitors (c-KitTer119; Figure 2A).the neo-Pax5-GFP insertion generated an Ik null allele.
GFP expression was only lost in the more mature
c-KitTer119 erythroblasts, demonstrating that thePan-Hematopoietic Expression
of the Targeted Ik Alleles transcription of the Ikaros gene is downregulated during
erythropoiesis (Figure 2C). Both heterozygous knockinRT-PCR analysis previously demonstrated that the
Ikaros gene is expressed in all hematopoietic cell types mice also expressed GFP at a similarly high level in long-
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Figure 2. Pan-Hematopoietic Expression of the Ikneo and IkPax5 Alleles
(A) GFP expression in different hematopoietic cell types. Bone marrow cells and thymocytes of 3-week-old heterozygous mice were stained
with lineage-specific antibodies, and GFP expression of the Ikaros knockin alleles (black surface) was displayed for erythroid progenitors
(c-KitTer119), granulocytes (Gr-1Mac-1), monocyte/macrophages (M-CSF-RMac-1), B cells (B220CD19), and immature thymocytes
(CD4CD8). Stippled lines refer to GFP wild-type cells.
(B) Expression of the Ikaros knockin alleles in long-term HSCs. Bone marrow cells of 8-week-old mice were stained and gated as indicated
to reveal GFP expression in Sca-1c-KitFlt3Lin stem cells of heterozygous mice (black surface) compared to wild-type littermates (black line).
(C) Downregulation of GFP expression during erythropoiesis. GFP expression is displayed for total bone marrow cells that were stained with
an anti-Ter119 antibody.
(D) Expression of the B cell marker CD19 on thymocytes of 3-week-old IkPax5/ mice.
term HSCs (Figure 2B), which were defined as Sca-1c- CD19 (data not shown), indicating that Pax5 is able to
activate the CD19 gene only in cooperation with otherKitFlt3Lin cells of the bone marrow (Christensen and
Weissman, 2001). We conclude therefore that the two lymphoid-restricted transcription factors. CD19 expres-
sion was also not observed on Ikneo/ thymocytes (Figuretargeted Ik alleles are uniformly expressed throughout
hematopoiesis, with the notable exception of erythro- 2D), consistent with the absence of Pax5 protein by
Western blot analysis (Figure 1D). These data thereforeblasts.
The scanning model of eukaryotic translation initiation demonstrate that the IkPax5 allele gives rise to pan-hema-
topoietic expression of Pax5 in contrast to the control(Kozak, 1999) predicts that the neo open reading frame
located upstream of the Pax5 cDNA (Figure 1A) should Ikneo allele, which fails to direct Pax5 protein synthesis.
prevent the synthesis of Pax5 protein from the Ikneo tran-
script. As shown by Western blot analysis, only traces Increased B Lymphopoiesis upon Conditional
Activation of the Ikneo Alleleof Pax5 protein could be detected in thymocytes and
sorted Mac-1 bone marrow cells of Ikneo/ mice due to The effect of precocious Pax5 expression was first stud-
ied in the context of the fully developed hematopoietica minor B cell contamination (Figure 1D). In contrast,
the IkPax5/ thymocytes and myeloid cells expressed the system of adult Ikneo/ mice. To this end, we crossed the
Ikneo allele into mice carrying the interferon-inducible Mx-Pax5 protein at similar levels compared to wild-type
pro-B cells (Figure 1D). The ectopically expressed Pax5 cre transgene, which facilitates high Cre recombinase
expression upon treatment with type I interferons (IFNprotein was also functional, as it led to transcription of
the Pax5 target gene CD19 (Kozmik et al., 1992; Nutt et or IFN) or with double-stranded RNA (polyinosine-poly-
cytosine [pIpC]) (Ku¨hn et al., 1995). The Mx-cre trans-al., 1998) in all IkPax5/ thymocytes (Figure 2D). The my-
eloid cells of IkPax5/ mice failed, however, to express gene was successfully used to delete floxed sequences
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in the stem cell, early progenitors, and later stages of Skewing of Hematopoietic Development
by Constitutive IkPax5 Expressionhematopoiesis (Ku¨hn et al., 1995; Radtke et al., 1999).
We next investigated the development of the differentHowever, IFN/ and pIpC are also known to reversibly
hematopoietic lineages in heterozygous IkPax5/ mice,inhibit erythroid and lymphoid development by eliminat-
which constitutively expressed the Pax5 minigene asing early progenitors of these lineages, whereas the dif-
soon as the transcription of the endogenous Ikaros locusferentiation of Mac-1 myeloid cells remains unaffected
was initiated in hematopoietic stem cells of the embryo.by IFN treatment (Lin et al., 1998). In our experimental
Ikneo/ mice were used as a reference, since the heterozy-system, we therefore studied the recovery of early hema-
gous Ik mutation is known to cause only a mild activationtopoietic development from type I IFN exposure, which
phenotype in mature T cells (Avitahl et al., 1999). We firstwas used to activate the Ikneo allele by Cre-mediated
determined the frequency of the different hematopoieticdeletion of the neo gene. pIpC was injected three times
progenitors in the fetal liver and adult bone marrow ofat 2 day intervals into Ikneo/ Mx-cre mice, and the cellular
both genotypes by limiting dilution analysis and methyl-composition of the bone marrow and thymus was ana-
cellulose colony assay. At embryonic (E) day 13.5, al-lyzed by flow cytometry at day 6, 16, and 23 after the
ready 1 of 15 fetal liver cells was identified as a Blast injection (Figure 3). Ikneo/ mice lacking the Mx-cre
lymphoid progenitor in IkPax5/ embryos in contrast to 1transgene were similarly treated to serve as a reference
out of 200 fetal liver cells in control Ikneo/ embryos (Fig-for the recovery of hematopoietic development in the
ure 4A). At this early time point, B cell development wasabsence of ectopic Pax5 expression.
therefore 13-fold increased by constitutive IkPax5expres-At day 6 after pIpC injection, the Ikneo/ Mx-cre mice
sion, which is comparable to the initial induction ob-contained on average nine times more B lymphocytes
served upon conditional IkPax5 activation (Figures 3A and(CD19B220) in the bone marrow compared to control
3C). The B lymphoid progenitors were maintained at theIkneo/ mice (Figures 3A and 3C). This massive increase
same high level in the E18.5 fetal liver and 2-week-oldin B cell development was the consequence of a 17-
bone marrow of IkPax5/ mice, while the number of B cellfold expansion of early pro-B cells (c-KitB220) and
progenitors was steadily increasing in control mice, thuswas sustained until day 23 (Figures 3A and 3C). The
reducing the difference between the two genotypes withTer119 erythroblasts were initially present at similarly
progressing age (Figure 4A). The number of erythroid-low levels in mice of both genotypes, but then reverted
restricted clonogenic precursors (CFU-E) did not signifi-to normal levels only in the control mice (Figures 3A and
cantly differ during embryogenesis and the first 2 weeks3C). The number of erythroid progenitors (c-KitTer119)
after birth, but then started to decline more rapidly at 5was significantly decreased, thus accounting for the re-
and 8 weeks in the IkPax5/ bone marrow compared toduced erythropoiesis in pIpC-treated Ikneo/ Mx-cre mice
the Ikneo/ control (Figure 4C). This decrease in erythroid(Figures 3A and 3C). In contrast, the differentiation of
development became more evident when the frequencymyeloid cells (Gr-1Mac-1) remained largely unaf-
of the most immature erythroid-restricted precursorsfected throughout the time course analyzed (Figures 3A
(BFU-E) was analyzed. The number of these precursorsand 3C).
continuously decreased in the IkPax5/ bone marrow toWithin the lymphoid system, the increase of B lympho-
reach only 1/20 of the level of control Ikneo/ mice at 8poiesis occurred at the expense of T cell development
weeks (Figure 4B). In contrast, the clonogenic precur-(Figures 3B and 3D). At day 6, the cellularity of the thy-
sors with granulocyte (CFU-G)- or macrophage (CFU-mus was equally low in pIpC-treated mice of both geno-
M)-restricted potential were present at similar numberstypes and thereafter recovered only in Ikneo/ mice,
in IkPax5/ and Ikneo/ mice both during fetal and adultwhereas it was further decreased in Ikneo/ Mx-cre mice
hematopoiesis with one exception (Figures 4D and 4E).until day 23 (Figure 3D). As shown by the analysis of CD4
The granulocyte precursors (CFU-G) were consistentlyand CD8 expression, the different thymocyte subsets of
2-fold reduced in the E18.5 fetal liver of IkPax5/ embryoscontrol and experimental mice were present in similar
compared to control Ikneo/ embryos.numbers at day 6 (Figures 3B and 3D). However, the
The results of these clonal assays were confirmed bythymocytes of pIpC-treated Ikneo/ Mx-cre mice still car-
flow cytometric analyses. At E18.5, the fetal liver of
ried the floxed neo gene and thus failed to express CD19
IkPax5/ embryos contained on average 7-fold more B
at day 6 (Figure 3B; data not shown), in agreement with lymphocytes (CD19B220) and 2.4-fold fewer granulo-
published data demonstrating only a low activity of the cytes (Gr-1Mac-1) than Ikneo/ embryos (Figure 4F). At
Mx-cre transgene in thymocytes (Ku¨hn et al., 1995; 8 weeks, the pro-B cells (c-KitB220) were still 3.5-
Radtke et al., 1999). In contrast, most thymocytes of the fold increased in the IkPax5/ bone marrow, resulting in a
Ikneo/ Mx-cre mice expressed CD19 at day 23 after pIpC modest increase of total B lymphocytes (B220; Figure
injection, suggesting that these cells developed from 4G). The early erythroid progenitors (c-KitTer119)
newly immigrated lymphoid progenitors of the bone were present below the detection limit, while the more
marrow (Figure 3B). At the same time, the number of mature erythroblasts (c-KitTer119) were reduced
CD4CD8double-positive (DP) thymocytes was signifi- 2-fold in the IkPax5/ bone marrow (Figure 4G). In contrast,
cantly reduced, whereas the relative percentage of NK cells (DX5TCR), granulocytes (Gr-1Mac-1),
CD4CD8 double-negative (DN) and CD4CD8 sin- and monocyte/macrophages (M-CSF-RMac-1) were
gle-positive (SP) cells was increased compared to con- present at similar numbers in the bone marrow of both
trol mice (Figure 3B). We conclude therefore that ectopic genotypes (Figure 4G). Hence, constitutive Pax5 misex-
Pax5 expression results in abnormal T cell development pression affected bone marrow hematopoiesis in a simi-
by reducing the potential of lymphoid progenitors in the lar manner as conditional activation of the IkPax5 allele.
bone marrow to contribute to T lymphopoiesis in the In both cases, pan-hematopoietic expression of Pax5
led to a sustained increase in B cell development andthymus.
Lineage Skewing by Precocious Pax5 Expression
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Figure 3. Increased B Cell Development upon Activation of the IkPax5 Allele
(A and B) Effect of conditional Pax5 expression on hematopoietic development. Ikneo/ mice carrying () or lacking (–) the Mx-cre transgene
were injected at the age of 4–5 months three times at 2 day intervals with pIpC, and the expression of the indicated antigens on cells of the
bone marrow (A) and thymus (B) was analyzed by flow cytometry at day 6 or 23 after the last injection. The percentage of cells in each
quadrant is indicated.
(C) Statistical analysis of the flow cytometric data. Bone marrow cells from pIpC-treated Ikneo/ mice carrying (black bar) or lacking (open bar)
the Mx-cre transgene were stained with the indicated antibodies. At least three mice were analyzed for each time point and genotype, and
the relative number of the different cell types is shown as percentage of the total bone marrow.
(D) Decreased thymic cellularity upon conditional Pax5 activation. The average number of thymocytes was determined for minimally three
mice at each time point. Mice on the C57BL/6x129/Sv background were analyzed (A–D).
to a moderate decrease in erythropoiesis, whereas the Flow cytometric analysis of CD4 and CD8 expression
revealed a grossly abnormal distribution of the differentgeneration of granulocytes, macrophages, and NK cells
remained largely unaffected. thymocyte subsets in 2-week-old IkPax5/ mice (Figures
5B and 5C). The absolute number of the most immature
DN thymocytes was increased 4.8-fold in IkPax5/ micePartial Block of T Cell Development at the DN3
compared to control mice. In contrast, the immature DPStage in IkPax5/ Mice
cells and the more mature CD8 SP cells were decreasedThe cellularity of the thymus in IkPax5/ mice continuously
by a factor of 3, whereas the number of CD4 SP cellsdecreased with progressive age, reaching a 5-fold lower
level at 8 weeks compared to control mice (Figure 5A). appeared to remain constant (Figure 5C). These obser-
Immunity
786
Lineage Skewing by Precocious Pax5 Expression
787
Figure 5. Partial Block of T Cell Development in IkPax5/ Mice
(A) Decreased cellularity of the thymus in IkPax5/ mice. The average number of thymocytes was determined for four mice of each genotype
at 2, 5, and 8 weeks (w) after birth.
(B) Representative flow cytometric analysis of CD4 and CD8 expression on gated Thy1.2 thymocytes from 2-week-old Ikneo/ and IkPax5/ mice.
(C) Absolute cell numbers were calculated for each thymocyte subset based on the total thymocyte number and the percentage of each
subset as determined in (B). The average numbers with standard deviations are shown for six mice each.
(D) Partial block of T cell development at the DN3 stage in IkPax5/ mice. The CD44/CD25 and Thy1.2/CD19 expression profiles are displayed
for DN thymocytes, which were gated as lineage-negative (Lin) cells. Mice on the 129/Sv background were analyzed (A–D).
vations indicate that the ectopic expression of Pax5 in (DN2) cells were 10-fold reduced relative to the
CD44CD25 (DN3) cells, which constituted the majorityearly thymocytes causes a partial developmental block
at the DN to DP transition, thus leading to the accumula- (95%) of the pro-T cells in IkPax5/ mice in contrast to the
control Ikneo/ mice (Figure 5D). Moreover, the IkPax5/ DN3tion of DN cells.
We next analyzed the DN cell compartment to further cells expressed the B cell marker CD19 on their surface,
indicating that they all transcribed the IkPax5 allele (Figurecharacterize the stage of developmental arrest in the
IkPax5/ thymus. Based on the differential expression of 5D). We conclude therefore that ectopic Pax5 expres-
sion arrests early T cell development at the DN3 stage.CD44 and CD25, pro-T cell development can be divided
into four stages, progressing from CD44CD25 (DN1) The transition from DN3 to DN4 cells is known to depend
on signaling from the pre-T cell receptor (pre-TCR; vonprogenitors through the CD44CD25 (DN2) and
CD44CD25 (DN3) stages to CD44CD25 (DN4) cells Boehmer et al., 1999). Hence, our data suggest that
Pax5 expression in early thymocytes interferes with the(Godfrey et al., 1993). The CD44/CD25 expression profile
of Lin DN thymocytes revealed that the CD44CD25 function of the pre-TCR checkpoint.
Figure 4. Hematopoietic Development in IkPax5/ Mice
(A) Increased abundance of B cell progenitors in IkPax5/ mice. Limiting dilution analysis in the presence of IL-7 and ST2 cells was used to
determine the number of B cell progenitors in the fetal liver at embryonic (E) day 13.5 and 18.5 as well as in the bone marrow of 2-week (w)-
old mice of the indicated genotypes. n, number of mice analyzed. (B–E) Methylcellulose colony assays. Myeloid and erythroid progenitors of
wild-type (wt), Ikneo/, and IkPax5/ mice were quantitated as colony (CFU)- or burst (BFU)-forming units in cells of the fetal liver at E13.5 and
E18.5 as well as in the bone marrow at 2, 5, and 8 weeks after birth. The data of Ikneo/ and IkPax5/ mice are presented as percentage relative
to the colony frequencies of wild-type mice (dashed line). Erythroid (E), granulocytic (G), and monocytic (M) colonies were evaluated as
described in the Experimental Procedures. (F) Increased B lymphopoiesis in IkPax5/ embryos at E18.5. The fetal liver of Ikneo/ and IkPax5/
embryos was analyzed by flow cytometry, and representative data of 15 embryos analyzed are shown. (G) Hematopoietic development in 8-
week-old IkPax5/ mice. The bone marrow of Ikneo/ and IkPax5/ mice was analyzed by flow cytometry, and the percentage of the different cell
types is shown for representative mice of each genotype. Mice on the 129/Sv genetic background were analyzed (A–G).
Immunity
788
Figure 6. Differential Contribution of the IkPax5/ HSC to Hematopoiesis in Mixed Bone Marrow Chimeras
(A) Bone marrow hematopoiesis. Bone marrow cells from IkPax5/ (Ly5.2) and wild-type (Ly5.1) mice were used at a ratio of 10:1 to reconstitute
lethally irradiated syngeneic recipient (Ly5.2) mice. The bone marrow of a representative chimeric mouse was analyzed by flow cytometry at
Lineage Skewing by Precocious Pax5 Expression
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Ectopic Pax5 Expression Prevents T Lymphopoiesis tection assay to express 5-fold lower levels of Notch1
mRNA compared to Pax5/ pro-B cells (Figure 7A). Sec-in Mixed Bone Marrow Chimeras
We next assessed the effect of pan-hematopoietic Pax5 ond, we studied the kinetics of Notch1 repression by
taking advantage of Pax5/ pro-B cells expressing theexpression in a competitive repopulation assay by re-
constituting lethally irradiated C57BL/6 mice (Ly5.2) with hormone-inducible Pax5 estrogen receptor (ER) fusion
protein (Nutt et al., 1998). Estrogen treatment of thesea 2:1 mixture of syngeneic IkPax5/ (Ly5.2) and wild-type
(Ly5.1) bone marrow. The analyses of several mixed KO-Pax5-ER cells for 16 hr resulted not only in activation
of the Pax5 target gene CD19 but also in a 5-fold down-chimeras at 2, 3, and 4 months after transplantation
revealed only a low chimerism, as on average 12% of regulation of Notch1 transcription (Figure 7A). Third, we
monitored Notch1 expression following conditional in-all bone marrow cells expressed GFP and were thus
derived from the IkPax5/ HSC (data not shown). This low activation of the floxed (F) Pax5 alleles in Pax5F/F CreED-
30 pro-B cells expressing a Cre-ER fusion protein (Mik-chimerism remained constant over time and was even
observed, if bone marrow from heterozygous Ik/ mice kola et al., 2002). In this induction system, the floxed
exon 2 of Pax5 was efficiently deleted within 1 day of(Wang et al., 1996) was used as competitor instead of
wild-type cells (data not shown). Moreover, reconstitu- Cre-ER activation by 4-hydroxytamoxifen (OHT; Figure
7B). The appearance of the truncated Pax5 mRNA wastion with a mixture of Ik/ and wild-type bone marrow
failed to reveal any bias in HSC engraftment (data not rapidly followed by the derepression of Notch1 and
J-chain expression. Interestingly, the J-chain gene isshown), thus indicating that the inefficient contribution
of the IkPax5/ HSC to hematopoiesis is not caused by the known to be directly repressed by Pax5 (Rinkenberger
et al., 1996). Hence, the similar kinetics of Notch1 andheterozygous state of the Ikaros mutation, but instead is
a direct consequence of the ectopic Pax5 expression. J-chain reactivation upon Pax5 loss suggests that
Notch1 is also a direct target of Pax5-mediated repres-In a second series of transplantation experiments,
we used a 10:1 mixture of IkPax5/ and wild-type bone sion. Finally, the same inverse correlation between Pax5
and Notch1 expression was also observed in c-KitB220marrow, which resulted in a 5-fold higher chimerism
(Figure 6). At 6.5 months after transplantation, GFP ex- pro-B cells that were directly sorted from the bone mar-
row of RAG2/ and Pax5/ mice (Figure 7C). We con-pression was observed in 62% of the c-KitSca1Lin
HSCs and in 52% of total bone marrow minus erythro- clude therefore that the repression of Notch1 by Pax5
provides a molecular mechanism for the suppression ofblasts, which were excluded from the analysis (Figure
6A) due to downregulation of the Ly5 (CD45) and GFP early T cell development in IkPax5/ mice.
(Ikaros) markers in these cells (Figure 2C). The pro-B
cells (c-KitB220) and B cells (CD19B220) preferen- Discussion
tially developed from the IkPax5/ HSC (94% and 87%),
whereas the early erythroid progenitors (c-KitTer119) We have previously shown by loss-of-function analysis
that Pax5 is essential for the commitment and develop-were predominantly of wild-type origin (85%; Figure 6A).
Moreover, the HSCs of both genotypes participated with ment of the B lymphoid lineage (Nutt et al., 1997, 1999;
Rolink et al., 1999). Here we have used a gain-of-functionsimilar efficiency in the development of granulocytes
(Gr-1Mac-1), dendritic cells (CD11cMac-1), and NK strategy to investigate whether pan-hematopoietic ex-
pression of Pax5 under the control of the Ikaros locuscells (DX5TCR). Most conspicuously, the IkPax5/ HSC
completely failed to contribute to T cell development in is sufficient to promote B cell development at the ex-
pense of other hematopoietic lineages. Three differentthe thymus, as no significant GFP expression could be
detected in all four thymocyte subsets (Figure 6B). The experimental approaches, based on conditional activa-
tion of the IkPax5 allele, constitutive Pax5 misexpression,absence of GFP expression in the DN cells indicates
that the Pax5-expressing lymphoid progenitors derived and competitive bone marrow reconstitution, dem-
onstrated that pan-hematopoietic Pax5 expressionfrom the IkPax5/ HSC failed to undergo commitment to
the T lymphoid lineage in the presence of competing strongly increased B lymphopoiesis at the expense of
T cell development and, to a lesser extent, of erythropoi-wild-type progenitors. Instead, the Pax5-expressing
lymphoid progenitors were efficiently shunted into the esis (Figure 7D). In fact, T lymphopoiesis was dramati-
cally reduced in IkPax5/ mice and entirely lost in mixedB cell pathway, whereas only the wild-type progenitors
gave rise to T cell development. bone marrow chimeras, where IkPax5/ progenitors were
unable, in competition with wild-type progenitors, to
contribute to T cell development (Figure 7D). EctopicRepression of Notch1 Transcription by Pax5
As Notch1 is essential for specifying the T cell fate (Radtke Pax5 expression also reduced the repopulation effi-
ciency of the HSC following cell transfer, whereas it didet al., 1999; Pui et al., 1999), we investigated by different
approaches whether Pax5 is able to repress Notch1 not appear to interfere with the maintenance of stem
cell function during the first 6 months analyzed (Figuretranscription in lymphoid progenitors. First, in vitro cul-
tured wild-type pro-B cells were shown by RNase pro- 7D). The reduced repopulation potential of the IkPax5/
6.5 months after transplantation. The different cell populations are indicated by their gate and percentage of the total bone marrow. The HSC
was defined as c-KitSca1Lin cells. The GFP expression profile of the gated cells is shown to the right together with the relative percentage
of GFP and GFP cells. The chimerism of the total bone marrow was determined by excluding the GFPLy5.1 erythroblasts.
(B) T lymphopoiesis. IkPax5/ progenitors were unable to contribute to T cell development, as no significant GFP expression could be detected
in the four thymocyte subsets defined by CD4 and CD8 expression.
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Figure 7. Repression of Notch1 Transcription by Pax5 in Lymphoid Progenitors
(A) Quantitation of CD19, Notch1, and control S16 mRNA in cultured wild-type (/) and Pax5 mutant (/) pro-B cells by RNase protection
assay. Pax5/ pro-B cells expressing the Pax5-ER protein (KO-Pax5-ER cells; Nutt et al., 1998) were treated for 16 hr with -estradiol (E2, 1
M) prior to analysis. The Notch1 signal of three experiments, which was quantitated on a PhosphorImager and normalized to the S16 mRNA,
is shown to the left as relative increase compared to the 16 hr time point or wild-type pro-B cells.
(B) Derepression of Notch1 upon loss of Pax5 expression. Pax5F/F CreED-30 pro-B cells expressing the Cre-EBD(G512R) protein (Mikkola et
al., 2002) were treated with 4-hydroxytamoxifen (OHT) for the indicated days prior to RT-PCR analysis. FL, full-length Pax5 transcript; E2,
truncated mRNA lacking Pax5 exon 2.
(C) Inverse correlation between Pax5 and Notch1 expression in c-KitB220 pro-B cells directly sorted from RAG2/ and Pax5/ bone marrow.
(D) Summary of hematopoietic development in IkPax5/ mice. The effect of pan-hematopoietic Pax5 expression on the different lineages is
indicated in red color. T cell development, which is strongly reduced in IkPax5/ mice, is entirely lost in chimeric mice generated by competitive
bone marrow reconstitution. n.d., not determined; CLP, common lymphoid progenitor; CMP, common myeloid progenitors; ErP, erythrocyte
precursor; GMP, granulocyte-macrophage precursor; HSC, hematopoietic stem cell; MEP, megakaryocyte-erythrocyte precursor; MkP, mega-
karyocyte precursor; and MPP, multipotent progenitor.
HSC is likely caused by a homing defect following trans- of early erythroid progenitors that were identified as
c-KitTer119 cells or by their BFU-E activity in colonyplantation, as HSCs were present at similar numbers in
the bone marrow of wild-type and IkPax5/ mice. assays. The expression of the IkPax5 allele was, however,
downregulated during subsequent erythropoiesis (Fig-
ure 2A), which may explain the moderate reduction ofPax5 and Myeloid Development
Hematopoietic progenitors are known to promiscuously the more mature CFU-E precursors, leading on average
to a 2-fold decrease of erythroblasts in the bone marrowexpress genes from different lineage-specific programs.
This multilineage priming of gene expression is thought of IkPax5/ mice.
A surprising result was the finding that ectopic Pax5to be the underlying cause for the developmental plas-
ticity of early progenitors (Hu et al., 1997). At B lineage expression did not interfere with normal development of
dendritic cells, granulocytes, and macrophages (Figurecommitment, the “lineage-inappropriate” genes are re-
pressed and B cell-specific genes are simultaneously 7D). This lack of interference was not caused by inactiv-
ity of the IkPax5 allele in the myeloid lineages, as the Mac-activated by the endogenous Pax5 protein, which itself
is expressed only at the onset of B cell development 1 bone marrow cells of IkPax5/ mice expressed both
GFP and the Pax5 protein at a similar level as B lympho-(Nutt et al., 1999). cDNA microarray analyses identified
many of the repressed targets as erythroid- or myeloid- cytes (Figures 1D and 2A). We have previously shown
that the endogenous Pax5 protein represses the myeloidspecific genes (A. Delogu, A. Schebesta, and M.B, un-
published data). Hence, it may not be surprising that M-CSF-R gene at the onset of B cell development (Nutt
et al., 1999; Mikkola et al., 2002). Interestingly however,ectopic Pax5 expression interfered with the formation
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the ectopically expressed Pax5 protein was unable to et al., 2002). Upon ligand binding, the intracellular do-
main is cleaved from the Notch1 receptor and functionsrepress the transcription of the M-CSF-R gene in Mac-
as a transcription factor to initiate T cell-specific gene1Gr-1 monocyte/macrophages (Figure 4G). Tran-
expression in lymphoid progenitors (Izon et al., 2002).scription of the M-CSF-R gene is known to critically
Notch1 appears to be the T cell equivalent of the Bdepend on the Ets-family protein PU.1, which also con-
lineage commitment factor Pax5, as it has been impli-trols the myeloid expression of other cytokine receptor
cated in T lineage specification by gain- and loss-of-genes (DeKoter et al., 1998). High levels of PU.1 expres-
function experiments (Pui et al., 1999; Radtke et al.,sion are required for myeloid differentiation, whereas
1999). Retroviral expression of the intracellular Notch1low PU.1 expression promotes B cell development (De-
domain in hematopoietic progenitors induces T cell de-Koter and Singh, 2000). Accordingly, the M-CSF-R
velopment at the expense of B lymphopoiesis in themRNA levels are high in myeloid cells and low in uncom-
bone marrow and has thus precisely the opposite effectmitted Pax5-deficient pro-B cells (Nutt et al., 1999). The
of ectopic Pax5 expression on the B versus T lineageanalysis of the M-CSF-R gene therefore suggests that
choice (Pui et al., 1999). On the other hand, conditionalPax5 is able to repress myeloid gene transcription only
inactivation of Notch1 in HSCs arrests T cell develop-in the PU.1low lymphoid compartment, whereas its re-
ment even before the earliest DN1 precursor stagepression activity is neutralized by the abundance of my-
(Radtke et al., 1999), which resembles the inability ofeloid transcription factors in PU.1high cells.
the IkPax5/ HSC to contribute to early T cell development
in mixed bone marrow chimeras. Consistent with thesePax5 and Lymphoid Development
observations, we have shown that Pax5 represses theThe normal development of myeloid progenitors argues
transcription of Notch1 in lymphoid progenitors. Thethat the precocious Pax5 expression caused a strong
function of Notch1 is known to be affected even by aincrease in B lymphopoiesis by efficiently directing
2-fold expression change, as heterozygous Notch1/lymphoid progenitors into the B cell pathway (Figure
HSCs contribute about five times less efficiently to thy-7D). Early B cell development depends on the three
mocyte development compared to wild-type HSC intranscription factors E2A, EBF, and Pax5. E2A and EBF
competitive bone marrow repopulation assays (Wash-act upstream of Pax5 in the genetic hierarchy of B cell
burn et al., 1997). It is therefore likely that the observeddevelopment, as the earliest B lymphoid progenitors are
5-fold repression of Notch1 transcription by Pax5 is suf-absent in mice lacking E2A or EBF, whereas Pax5/
ficient to prevent T lineage commitment of IkPax5/pro-B cells express E2A, EBF, and their target genes at
lymphoid progenitors, which are in competition withnormal levels (reviewed by Schebesta et al., 2002a). It
wild-type progenitors in mixed bone marrow chimeras.is therefore likely that ectopic Pax5 expression is suffi-
Under noncompetitive conditions, the lymphoid progen-cient to promote B cell development only in lymphoid
itors of IkPax5/ mice could give rise to T cell development,progenitors coexpressing E2A and EBF. Our data also
which was, however, grossly abnormal. The first devel-suggest that the activation of the endogenous Pax5
opmental arrest within the T lymphoid lineage occurredgene is a rate-limiting process in early B cell develop-
at the DN3 stage in IkPax5/ mice, suggesting that Pax5
ment, which contributes to the homeostasis of lymphoid
misexpression interferes with the checkpoint function
progenitors in wild-type mice. Precocious Pax5 expres-
of the pre-TCR. This block may also be caused by the
sion bypasses this rate-limiting step and thus deprives
Pax5-dependent repression of Notch1 in view of the
the lymphoid progenitors of other developmental op- recent finding that conditional inactivation of Notch1 in
tions by efficiently shunting them into the B cell pathway. DN2 cells arrests pro-T cell development at the DN3
Primitive hematopoiesis in the embryonic yolk sac stage due to inefficient V-to-DJ recombination of the
does not support lymphoid development, as it is entirely TCR locus (Wolfer et al., 2002). Later abnormalities of
restricted to erythro-myeloid differentiation (Cumano et T cell development could result from the ectopic activa-
al., 2001). Since the IkPax5 allele was expressed in hema- tion of B lymphoid genes, which is best evidenced by
topoietic cells of the yolk sac (data not shown), we inves- the expression of the B cell marker CD19 on all IkPax5/
tigated whether ectopic Pax5 expression could enforce thymocytes.
B cell development in this early hematopoietic organ. Surprisingly, ectopic Pax5 expression did not interfere
To this end, the yolk sac was isolated from IkPax5/ em- with the generation of NK cells that constitute the third
bryos at day 8.5 prior to the circulation of hematopoietic lymphoid lineage. The transcription factor Id2 is not only
cells and was then kept for 4 days as an explant in organ expressed in NK cell progenitors (Ikawa et al., 2001)
culture followed by analysis of the different hematopoi- but is also required for the development of this lineage
etic cell types (Cumano et al., 2001). Despite ectopic (Yokota et al., 1999). The Id2 protein functions as a
Pax5 expression, B cell progenitors could not be de- negative regulator by sequestering bHLH proteins such
tected by limiting dilution analysis in these explants that as E2A into inactive heterodimers. It is therefore con-
instead gave rise to erythroid and myeloid development ceivable that the expression of Id2 in lymphoid progeni-
similar to the wild-type yolk sac tissue (data not shown). tors blocks the effect of ectopic Pax5 expression by
These data further support the notion that Pax5 is able inactivating the essential upstream regulator E2A of B
to promote B cell development only in cooperation with cell development.
other lymphoid transcription factors that are not yet In conclusion, our study unequivocally demonstrates
expressed in hematopoietic progenitors of the yolk sac. that Pax5 does not function as a master regulator of B
Early T cell development critically depends on Notch1 cell development, as its ectopic expression is unable to
signaling, which is activated by Delta and Jagged li- divert the HSC and erythro-myeloid progenitors into the
B cell pathway. Pax5 is, however, sufficient to promotegands expressed on stromal cells of the thymus (Izon
Immunity
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3 units/ml of human erythropoietin for CFU-E and BFU-E measure-B cell development within the lymphoid progenitor com-
ments. The number of B cell progenitors was quantitated by limitingpartment, where it interferes with T lymphopoiesis by
dilution assay as described (Rolink et al., 1993). In brief, single cellantagonizing Notch1 expression.
suspensions were plated at limiting dilutions on -irradiated ST2
cells in IMDM medium containing 1% conditioned medium of rIL-7-
Experimental Procedures
producing J558L cells (Nutt et al., 1999). Colonies consisting of	100
pro-B cells were scored on day 6, and the progenitor cell frequency
Generation of Knockin Mice
was calculated as described (Rolink et al., 1993).
The IkPax5 targeting vector was assembled in a pSP64 plasmid con-
taining a polylinker with appropriate loxP and restriction sites. A 1.9
Competitive Repopulation Assay
kb BsaI-XhoI fragment and a 4.8 kb NheI-PstI fragment of the Ik
Two-month-old mice (C57BL/6-Ly5.2) were -irradiated with a single
gene were inserted as homology arms together with a floxed tk-neo
dose of 12 Gy 24 hr prior to intravenous injection of 2 
 106 bone
gene (positive selection) and the human Pax5 cDNA linked via IRES
marrow cells from IkPax5/ mice (C57BL/6-Ly5.2) and 2 
 105 bone
to GFP and the rabbit -globin polyadenylation region. The HSV-tk
marrow cells from wild-type mice (C57BL/6-Ly5.1). The donor mice
and DT-A genes (negative selection) were inserted upstream of the
were 3 weeks old. The radiation chimeras were analyzed at 2, 4,
short homology arm. SgrAI-linearized DNA (15 g) was electropor-
and 6.5 months after transplantation.
ated into HM-1 ES cells (1 
 107) followed by selection with 250 g/
ml G418 and 2 M gancyclovir. PCR-positive clones were verified
Western Blot Analysisby Southern blot analysis of AvrII-digested DNA prior to injection
Mac-1 cells were isolated by magnetic sorting from the bone mar-into C57BL/6 blastocysts and the generation of Ikneo/ mice. IkPax5/
row of 3-week-old mice. Whole cell lysates were separated by 10%offspring were obtained from Ikneo/ mice carrying the Sycp1-cre
SDS-PAGE prior to Western blot analysis with monoclonal anti-transgene (Vidal et al., 1998). The Ikneo and IkPax5 alleles were back-
Ikaros (4E9; K. Georgopoulos), anti-TBP (3G3; L. Tora), anti-tubulincrossed into the 129/Sv and C57BL/6 genetic backgrounds for 	4
(TUB-1A2; Sigma), and polyclonal anti-Pax5 antibodies. The 4E9generations. Both knock-in alleles were identified by a 780 bp PCR
antibody recognizes a C-terminal epitope encoded by Ik exon 8.fragment, which was amplified from the rabbit -globin polyadenyla-
tion region with the primers 5-GCGGAGCTCCTCAGGTGCAGGCTG
RNase Protection and RT-PCR AnalysisCCTATC-3 and 5-CGCGTCGACGCTAACATCCTGAGGGACTGT-3.
Pro-B cells were cultured in the presence of IL-7 and ST2 cells
followed by RNase protection or RT-PCR analysis as describedMx-cre Activation
(Nutt et al., 1998; Mikkola et al., 2002). The Notch1 mRNA was
Mx-cre transgenic mice (Ku¨hn et al., 1995) were intraperitoneally
detected with a riboprobe containing Notch1 sequences from nucle-injected three times at 2 day intervals with 400 g of poly(I)-poly(C)
otide 6160 to 6460 (AF508809) or with the RT-PCR primers(Pharmacia, Uppsala, Sweden).
5-CTTCGTGCTCCTGTTCTTTGT-3 and 5-GGTGCGGTCTGTCTG
GTTGTG-3.
Antibodies and Flow Cytometry
The following phycoerythrin (PE)- or allophycocyanin (APC)-coupled
Acknowledgmentsantibodies were obtained from PharMingen (San Diego, CA): anti-
B220 (RA3-6B2), CD4 (L3T4), CD3 (145-2C11), CD8 (53-6.7), CD5
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was used for the analysis of all flow cytometric data shown. Long-
Received: April 25, 2002term HSCs were analyzed by staining bone marrow cells with APC-
Revised: September 25, 2002anti-c-Kit, biotinylated-anti-Sca1 (E13-161.7; detected with Cy-
Chrome-streptavidin), PE-anti-Flk-2/Flt3, and PE-coupled lineage
Referencesmarker antibodies (anti-B220, CD3, CD4, CD5, CD8, CD19, Gr-1,
Mac-1, and Ter119) as described (Christensen and Weissman, 2001).
Avitahl, N., Winandy, S., Friedrich, C., Jones, B., Ge, Y., and Georgo-DN thymocytes were defined by the absence of staining with the
poulos, K. (1999). Ikaros sets thresholds for T cell activation andlineage-specific anti-B220, CD3, CD4, CD8, TCR, DX5, CD11c,
regulates chromosome propagation. Immunity 10, 333–343.Mac-1, and Ter119 antibodies.
Christensen, J.L., and Weissman, I.L. (2001). Flk-2 is a marker in
hematopoietic stem cell differentiation: a simple method to isolateColony Assays
long-term stem cells. Proc. Natl. Acad. Sci. USA 98, 14541–14546.Colony assays were performed in duplicate by plating 2
 104 nucle-
ated fetal liver or bone marrow cells with 1.1 ml of MethoCult M3434 Cumano, A., Ferraz, J.C., Klaine, M., Di Santo, J.P., and Godin, I.
medium (StemCell Technologies, Vancouver) in 35 mm Petri dishes (2001). Intraembryonic, but not yolk sac hematopoietic precursors,
according to the manufacturer’s instructions. The culture conditions isolated before circulation, provide long-term multilineage reconsti-
correspond to 1% methylcellulose in Iscove’s Modified Dulbecco’s tution. Immunity 15, 477–485.
Medium (IMDM), 15% fetal bovine serum, 1% bovine serum albumin, DeKoter, R.P., and Singh, H. (2000). Regulation of B lymphocyte
10 g/ml bovine insulin, 200 g/ml human transferrin, 0.1 mM and macrophage development by graded expression of PU.1. Sci-
-mercaptoethanol, 2 mM glutamine, 10 ng/ml mouse IL-3, 10 ng/ ence 288, 1439–1441.
ml mouse IL-6, 50 ng/ml stem cell factor, and 3 units/ml human
DeKoter, R.P., Walsh, J.C., and Singh, H. (1998). PU.1 regulates both
erythropoietin. CFU-E colonies were scored at day 3 following incu-
cytokine-dependent proliferation and differentiation of granulocyte/
bation at 37C, while all other colonies were evaluated at day 7–8.
macrophage progenitors. EMBO J. 17, 4456–4468.
Pure erythroid (E) colonies at day 7–8 were scored as BFU-E, and
Godfrey, D.I., Kennedy, J., Suda, T., and Zlotnik, A. (1993). A devel-colonies containing at least 100 granulocytes (G) or macrophages
opmental pathway involving four phenotypically and functionally(M) were referred to as CFU-G or CFU-M, respectively. Single-factor
distinct subsets of CD3CD4CD8 triple-negative adult mouse thy-colony assays were independently used to evaluate the precursor
mocytes defined by CD44 and CD25 expression. J. Immunol. 150,frequencies by seeding 2 
 105 cells in 1.1 ml of MethoCult 3234
4244–4252.medium supplemented with 3 ng/ml mouse GM-CSF (R&D Systems)
for CFU-G/M colony determination or in MethoCult 3334 containing Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M., Heyworth,
Lineage Skewing by Precocious Pax5 Expression
793
C., and Enver, T. (1997). Multilineage gene expression precedes patterning of the posterior midbrain in mice lacking Pax5/BSAP.
Cell 79, 901–912.commitment in the hematopoietic system. Genes Dev. 11, 774–785.
Ikawa, T., Fujimoto, S., Kawamoto, H., Katsura, Y., and Yokota, Y. Vidal, F., Sage, J., Cuzin, F., and Rassoulzadegan, M. (1998). Cre
expression in primary spermatocytes: a tool for genetic engineering(2001). Commitment to natural killer cells requires the helix-loop-
helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 98, 5164–5169. of the germ line. Mol. Reprod. Dev. 51, 274–280.
von Boehmer, H., Aifantis, I., Feinberg, J., Lechner, O., Saint-Ruf,Izon, D.J., Punt, J.A., and Pear, W.S. (2002). Deciphering the role of
Notch signaling in lymphopoiesis. Curr. Opin. Immunol. 14, 192–199. C., Walter, U., Buer, J., and Azogui, O. (1999). Pleiotropic changes
controlled by the pre-T-cell receptor. Curr. Opin. Immunol. 11,Kelley, C.M., Ikeda, T., Koipally, J., Avitahl, N., Wu, L., Georgopoulos,
135–142.K., and Morgan, B. (1998). Helios, a novel dimerization partner of
Ikaros expressed in the earliest hematopoietic progenitors. Curr. Wang, J.-H., Nichogiannopoulou, A., Wu, L., Sun, L., Sharpe, A.H.,
Bigby, M., and Georgopoulos, K. (1996). Selective defects in theBiol. 8, 508–515.
development of the fetal and adult lymphoid system in mice withKlug, C.A., Morrison, S.J., Masek, M., Hahm, K., Smale, S.T., and
an Ikaros null mutation. Immunity 5, 537–549.Weissman, I.L. (1998). Hematopoietic stem cells and lymphoid pro-
genitors express different Ikaros isoforms, and Ikaros is localized Washburn, T., Schweighoffer, E., Gridley, T., Chang, D., Fowlkes,
B.J., Cado, D., and Robey, E. (1997). Notch activity influences theto heterochromatin in immature lymphocytes. Proc. Natl. Acad. Sci.
USA 95, 657–662.  versus  T cell lineage decision. Cell 88, 833–843.
Wolfer, A., Wilson, A., Nemir, M., MacDonald, H.R., and Radtke, F.Kozak, M. (1999). Initiation of translation in prokaryotes and eukary-
otes. Gene 234, 187–208. (2002). Inactivation of Notch1 impairs VDJ rearrangement and
allows pre-TCR-independent survival of early  lineage thymo-Kozmik, Z., Wang, S., Do¨rfler, P., Adams, B., and Busslinger, M.
cytes. Immunity 16, 869–879.(1992). The promoter of the CD19 gene is a target for the B-cell-
specific transcription factor BSAP. Mol. Cell. Biol. 12, 2662–2672. Wu, L., Nichogiannopoulou, A., Shortman, K., and Georgopoulos,
K. (1997). Cell-autonomous defects in dendritic cell populations ofKu¨hn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995). Inducible
Ikaros mutant mice point to a developmental relationship with thegene targeting in mice. Science 269, 1427–1429.
lympoid lineage. Immunity 7, 483–492.Lin, Q., Dong, C., and Cooper, M.D. (1998). Impairment of T and B
Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishi-cell development by treatment with a type I interferon. J. Exp. Med.
kawa, S.-I., and Gruss, P. (1999). Development of peripheral187, 79–87.
lymphoid organs and natural killer cells depends on the helix-loop-Mikkola, I., Heavey, B., Horcher, M., and Busslinger, M. (2002). Re-
helix inhibitor Id2. Nature 397, 702–706.version of B cell commitment upon loss of Pax5 expression. Science
297, 110–113.
Morgan, B., Sun, L., Avitahl, N., Andrikopoulos, K., Ikeda, T., Gonza-
les, E., Wu, P., Neben, S., and Georgopoulos, K. (1997). Aiolos, a
lymphoid restricted transcription factor that interacts with Ikaros to
regulate lymphocyte differentiation. EMBO J. 16, 2004–2013.
Nutt, S.L., Urba´nek, P., Rolink, A., and Busslinger, M. (1997). Essen-
tial functions of Pax5 (BSAP) in pro-B cell development: difference
between fetal and adult B lymphopoiesis and reduced V-to-DJ re-
combination at the IgH locus. Genes Dev. 11, 476–491.
Nutt, S.L., Morrison, A.M., Do¨rfler, P., Rolink, A., and Busslinger, M.
(1998). Identification of BSAP (Pax-5) target genes in early B-cell
development by loss- and gain-of-function experiments. EMBO J.
17, 2319–2333.
Nutt, S.L., Heavey, B., Rolink, A.G., and Busslinger, M. (1999). Com-
mitment to the B-lymphoid lineage depends on the transcription
factor Pax5. Nature 401, 556–562.
Pui, J.C., Allman, D., Xu, L., DeRocco, S., Karnell, F.G., Bakkour, S.,
Lee, J.Y., Kadesch, T., Hardy, R.R., Aster, J.C., et al. (1999). Notch1
expression in early lymphopoiesis influences B versus T lineage
determination. Immunity 11, 299–308.
Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., Mac-
Donald, H.R., and Aguet, M. (1999). Deficient T cell fate specification
in mice with an induced inactivation of Notch1. Immunity 10,
547–558.
Rinkenberger, J.L., Wallin, J.J., Johnson, K.W., and Koshland, M.E.
(1996). An interleukin-2 signal relieves BSAP (Pax5)-mediated re-
pression of the immunoglobulin J chain gene. Immunity 5, 377–386.
Rolink, A., Haasner, D., Nishikawa, S.-I., and Melchers, F. (1993).
Changes in frequencies of clonable pre-B cells during life in different
lymphoid organs of mice. Blood 81, 2290–2300.
Rolink, A.G., Nutt, S.L., Melchers, F., and Busslinger, M. (1999).
Long-term in vivo reconstitution of T-cell development by Pax5-
deficient B-cell progenitors. Nature 401, 603–606.
Schebesta, M., Heavey, B., and Busslinger, M. (2002a). Transcrip-
tional control of B cell development. Curr. Opin. Immunol. 14,
216–223.
Schebesta, M., Pfeffer, P.L., and Busslinger, M. (2002b). Control of
pre-BCR signaling by Pax5-dependent activation of the BLNK gene.
Immunity 17, 473–485.
Urba´nek, P., Wang, Z.-Q., Fetka, I., Wagner, E.F., and Busslinger,
M. (1994). Complete block of early B cell differentiation and altered
